Cargando…
The Challenge of Managing STEMI in the COVID-19 Epidemic
Autor principal: | Jolobe, Oscar M.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289486/ https://www.ncbi.nlm.nih.gov/pubmed/34294217 http://dx.doi.org/10.1016/j.jemermed.2021.01.042 |
Ejemplares similares
-
A new dimension to the STEMI-related mortality risk seen in the COVID-19 pandemic era
por: Jolobe, Oscar M.P.
Publicado: (2022) -
Priorities in the Evaluation of Hemophagocytic Lymphohistiocytosis Syndrome in the Emergency Department
por: Jolobe, Oscar M.P.
Publicado: (2021) -
COVID-19 sends STEMI to quarantine!?
por: Abdi, Seifollah, et al.
Publicado: (2020) -
Upper limit of the normal range for thyrotropin-stimulating hormone
is higher with increasing age
por: Jolobe, Oscar MP
Publicado: (2012) -
The exclusion of hypochromia from the iron deficiency screen
por: Jolobe, Oscar MP
Publicado: (2014)